Tempest Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $486 | $486 | $0 |
Gross Profit | -67 | -68 | 243 | -98 |
EBITDA | -7,966 | -10,631 | -13,517 | -10,129 |
EBIT | -8,033 | -10,699 | -13,566 | -10,226 |
Net Income | -7,870 | -10,860 | -13,813 | -10,556 |
Net Change In Cash | 0 | 486 | 486 | 0 |
Free Cash Flow | 8,036 | -8,036 | -10,152 | -10,197 |
Cash | 14,280 | 21,511 | 30,268 | 22,116 |
Basic Shares | 3,802 | 3,437 | 27,901 | 25,806 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -389 | -381 | -1,814 | -1,270 |
EBITDA | -40,138 | -28,776 | -32,277 | -25,716 |
EBIT | -40,527 | -29,157 | -34,091 | -26,986 |
Net Income | -41,843 | -29,491 | -35,709 | -28,302 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -33,462 | -27,527 | -31,634 | -26,092 |
Cash | 30,268 | 39,230 | 31,230 | 51,829 |
Basic Shares | 27,902 | 15,416 | 888 | 291 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$2.07 |
2025-03-31 | -$3.16 |
2024-12-31 | -$0.31 |
2024-09-30 | -$0.41 |
